Moderna, Pfizer and COVID-19

Moderna COVID Vaccine Technology Struck Down by PTAB
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s patents for its COVID-19 vaccine technology. The final written decisions remain sealed.
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of infringing were invalid.
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech traded blows this week with rival Moderna as dueling decisions came down in | Moderna sued Pfizer and BioNTech over three patents protecting its COVID-19 work back in 2022.
Pfizer and BioNTech COVID vaccine broke patent — German court
FRANKFURT - A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine.Siding with Moderna, an American pharmaceutical firm that brought the case,
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In a statement, the court in the city of Duesseldorf said that Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation,
Moderna wins patent lawsuit against BioNTech/Pfizer in German court
A German court ruled on Wednesday that BioNTech and Pfizer violated a Covid-19 patent held by rival Moderna. US-based Moderna had asserted claims for information and damages for infringement of its patent rights in the development of the Covid-19 vaccine.
Endpoints News3d
Mod­er­na stands by its Covid vac­cine IP af­ter de­ci­sion ax­ing two patents
Moderna says its long-running patent dispute with Pfizer and BioNTech isn't over even after a decision by an administrative ...
CNET on MSN4d
How the 3 New COVID Vaccines Change the Way You Pay
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...
Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges
Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from Genevant Sciences and Arbutus Biopharma targeting its LNP technology used in products like ...
Moderna: Patent Litigation Win Masks Underperformance, Unlikely To Pay Out
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
Among public companies, Covid created both winners and losers
The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...
'A group effort': Palm Beach worked collaboratively to manage early days of COVID-19
The police and fire-rescue departments partnered with the town manager’s office to guide the town’s COVID-19 response.
Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday
A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...
MRNA vaccines now face attacks from some in the GOP
The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...